Compare PVLA & DEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PVLA | DEC |
|---|---|---|
| Founded | 2015 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | N/A | N/A |
| Metric | PVLA | DEC |
|---|---|---|
| Price | $102.42 | $14.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 7 |
| Target Price | ★ $141.50 | $22.67 |
| AVG Volume (30 Days) | 292.1K | ★ 645.7K |
| Earning Date | 11-11-2025 | 03-20-2026 |
| Dividend Yield | N/A | ★ 8.13% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,148,432,000.00 |
| Revenue This Year | N/A | $126.94 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 64.19 |
| 52 Week Low | $11.17 | $10.08 |
| 52 Week High | $114.69 | $17.70 |
| Indicator | PVLA | DEC |
|---|---|---|
| Relative Strength Index (RSI) | 56.83 | 48.34 |
| Support Level | $99.00 | $13.72 |
| Resistance Level | $114.69 | $14.54 |
| Average True Range (ATR) | 8.59 | 0.45 |
| MACD | 0.18 | -0.06 |
| Stochastic Oscillator | 62.78 | 30.83 |
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.
Diversified Energy Co is an independent energy company focused on natural gas and liquids production, transportation, marketing and well retirement, located within the Appalachian and Central regions of the United States. Its principal focus is on enhancing producing wells, not drilling new wells, thereby allowing it to optimise PDP revenues and reduce costs. The company derives revenues from the sale of oil, natural gas and natural gas liquids.